Novartis: Carcinoma, Non-Small-Cell Lung trials
The registry lists 102 Carcinoma, Non-Small-Cell Lung studies with Novartis as lead sponsor. 8 are open to participants now and 39 have results posted.
Phase 1 44Phase 2 40Phase 3 16Phase 4 3No phase 9(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.